| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33c922e05f6133b7d72dbb849d77487d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4155 |
| filingDate |
2021-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57cadf2dc554ea57a03a49ddad6cf863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a0760a2cee9cbc213badbff01ab2fd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9e812d7e4453307ea0fb0ac3d650646
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08261911ba1bd888f1889803f95fc7bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbe610cd08ecff9ae2da6bfbba279dfa |
| publicationDate |
2022-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022119269-A1 |
| titleOfInvention |
Stable oral formulation containing 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid |
| abstract |
The present invention relates to a stable oral formulation containing 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid or a pharmaceutically acceptable salt thereof as an API. Being characterized by the maintenance of stability even though containing no stabilizers as excipients, the stable oral formulation according to the present invention contains an increased content of API in place of the inclusion of a stabilizer and as such, can be improved in terms of dose convenience. |
| priorityDate |
2020-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |